The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity firms have moved aggressively into the healthcare industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.
Stay updated with breaking news from Centex Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Private equity firms have moved aggressively into the healthcare industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.
After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials. To bring a new drug to market, the FDA requires pharmaceutical
Private equity firms have moved aggressively into the industry’s more hidden niches, pouring billions into the business of clinical drug trials.
After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry's more hidden niches: They are pouring billions into the business of clinical drug trials.
VERIFY: Yes, text message offering to get paid to participate in COVID-19 vaccine trial is real Cheryl Mercedes Replay Video UP NEXT There’s a text message going around asking people if they are interested in getting paid to participate in a COVID-19 vaccine trial. Someone thought it sounded too good to be true. So, they asked the VERIFY team to check it out. The text reads, “Interested in a paid COVID-19 vaccine clinical trial?” There’s a telephone number and email to contact someone at Centex Studies. Our source for this is Dr. Joe Pouzar, principal investigator at ...